CONJUGATES UTILIZING PLATFORM TECHNOLOGY FOR STIMULATING IMMUNE RESPONSE

Peptides presenting an epitope of a domain of factor H binding protein and methods of use

Chemically programmed vaccination

Immunogenic heat stable enterotoxin

IgE CH3 peptide vaccine

A-β immunogenic peptide carrier conjugates and methods of producing same

Treatment of atherosclerosis with cholesterol ester transport protein mimotopes

METHOD OF INDUCING AN ANTI-VIRAL IMMUNE RESPONSE

Stable immunogenic product comprising antigenic heterocomplexes

Composition for producing anti-amyloid beta peptide antibodies with D-peptides

Glycopeptide constructs and uses thereof

Targeting poly-γ-glutamic acid to treat and related infections

Vaccine for shigella

Immunotherapeutic compositions for the treatment of alzheimer'S disease

Immunogenic compounds comprising peptides of IL1β

PEPTIDE ANALOGUES AND CONJUGATES THEREOF

TRIMODAL CANCER THERAPY

IMMUNOTHERAPY COMPOSITIONS FOR THE TREATMENT AND PREVENTION OF AMYLOIDOSIS

Compositions of and method of using heat shock protein peptides

Influenza B Vaccines

Systems and methods for identifying replikin scaffolds and uses of said replikin scaffolds

Mimotopes of alpha-synuclein and vaccines thereof for the treatment of neurodegenerative disorders

Prostate cancer diagnosis and treatment

Anti-atheroma vaccine

PAX2 AND PAX8 AS TUMOUR TARGETS FOR IMMUNOLOGIC AND MOLECULAR TREATMENT STRATEGIES

IMMUNOGENIC COMPOSITIONS CAPABLE OF ACTIVATING T-CELLS

Composition of tumor-associated peptides and related anti-cancer vaccine for the treatment of glioblastoma (GBM) and other cancers

USE OF SACCHARIDES CROSS-REACTIVE WITH BACILLUS ANTHRACIS SPORE GLYCOPROTEIN AS A VACCINE AGAINST ANTHRAX

Idiotypic vaccine

Neutralizing immunogen (NimIV) of rhinovirus and its use for vaccine applications

THOMSEN-FRIEDENREICH DISACCHARIDE MODIFIED IMMUNOGEN (TFD), PREPARATION PROCEDURE, COMPOSITIONS COMPRISING IT, USES, AND TREATMENT METHODS

Immunogenic Compositions Containing Ceramide and Methods of Use Thereof

Antibodies against and methods for producing vaccines for respiratory syncytial virus

Peptide fragments reacting specifically with antibodies against highly pathogenic newcastle disease virus and uses thereof

Polysaccharide vaccine for infections

Systems and methods for identifying replikin scaffolds and uses of said replikin scaffolds

Anti-obese immunogenic hybrid polypeptides and anti-obese vaccine composition comprising the same

Antibodies for norovirus

Pneumococcal serotype 6D

Purified plasmodium and vaccine compositions

Conjugates of surface proteins as malaria vaccines

Immunotherapy against several tumors including neuronal and brain tumors

Globo H and related anti-cancer vaccines with novel glycolipid adjuvants

Generation of a cancer-specific immune response toward MUC1 and cancer specific MUC1 antibodies

Vaccines and methods for controlling adiposity

Method to reduce the physiologic effects of drugs on mammals

Immunogenic memapsin 2 β-secretase peptides and methods of use

CANCER VACCINE COMPRISING A MUCIN 1 (MUC1) T CELL EPITOPE-DERIVED PEPTIDE

COMPOSITIONS FOR INDUCING IMMUNE RESPONSES SPECIFIC TO GLOBO H AND SSEA3 AND USES THEREOF IN CANCER TREATMENT

Soluble Fragments of The Sars-Cov Spike Glycoprotein

Neurotoxic oligomers

Methods for identifying peptides that bind to intact oocytes

HER-2/NEU MULTI-PEPTIDE VACCINE

Concurrent chemotherapy and immunotherapy

Method for the preparation of specific antibodies against saccharidic antigens

VACCINE AGAINST NICOTINE ADDICTION

Immunogenic compositions capable of activating T-cells

Antibodies for the detection of and vaccine against infections

Vaccine for a therapeutic or a prophylactic treatment of myasthenia gravis

Immune adjuvant comprising ATP

Virus-like particles as vaccines for paramyxovirus

Polyvalent conjugate vaccine for cancer

Conjugation of streptococcal capsular saccharides

Cleavable vaccine compositions and uses thereof and methods of making and using the same

Modulation of developmental immune programming and protection against cardiovascular disease, diabetes, infectious diseases, and cancer

Isolated TNF-alpha peptide and pharmaceutical composition thereof

A-BETA IMMUNOGENIC PEPTIDE CARRIER CONJUGATES AND METHODS OF PRODUCING SAME

DNA vaccine

Optimal Polyvalent Vaccine for Cancer

REAGENTS FOR DETECTING EFAVIRENZ

Method for delivering an active agent using a hydrogel composition

Therapeutic Compositions that alter the immune response

Method of producing conjugate vaccines

Targeting Poly-Gamma-Glutamic Acid to Treat Staphylococcus Epidermidis and Related Infections

Method for preparing a stable immunogenic product comprising antigenic heterocomplexes of TNFα and a carrier protein

Immunological modulation of insulin-like growth factor 1 for cancer prevention/treatment and prolonging longevity

Aβ immunogenic peptide carrier conjugates and methods of producing same

GD3-mimetic peptides

Adjuvation Through Cross -Beta Structure

Anti-tumor vasculature effects of human serum albumin derivatives

Chimeric T helper-B cell peptide vaccine for Japanese encephalitis virus

Method to reduce the physiologic effects of drugs on mammals

Method to reduce the physiologic effects of drugs on mammals

Use of immunogens to treat or prevent, in malignant tumors, the immune or vascular disorders induced by extracellular factors

Antigen mimotopes and vaccine against cancerous diseases

Conserved inner core lipopolysaccharide epitopes as multi-species vaccine candidates

Conjugation of biomolecules using Diels-Alder cycloaddition

Vaccines directed to cancer-associated carbohydrate antigens

Methods of treating or preventing an infectious disease using an immunogenic conjugate of a gram-negative bacterial autoinducer molecule

Cat dander allergen treatments

High-yield method for the production of human antibodies blocking the biological activity of a human cytokine

Virus-like particles as vaccines for paramyxovirus

A-β immunogenic peptide carrier conjugates and methods of producing same

Vaccines directed to cancer-associated carbohydrate antigens

Nucleic acid molecule comprising a nucleic acid sequence which codes for a haemocyanin

Fragments or polymers of albumin with tunable vascular residence time for use in therapeutic delivery and vaccine development

Prostate cancer diagnosis and treatment

Systems and methods for identifying Replikin Scaffolds and uses of said Replikin Scaffolds

Soluble fragments of the SARS-CoV spike glycoprotein

Gp120 specific antigens and uses thereof

Prostate specific antigens and uses thereof

Combinations of growth-and hormone-regulating factors for the treatment of neoplasia

Ganglioside-KLH conjugate vaccine with QS-21

Immunosuppression

Vaccines against hiv-1 tat protein to generate neutralizing antibodies

Antibodies against and methods for producing vaccines for respiratory syncytial virus

Depletion of endogenous primordial germ cells in avian species

Use of passive myostatin immunization in egg laying vertebrates

Method of treatment using ligand-immunogen conjugates

Stable immunogenic product comprising antigenic heterocomplexes

GD3-mimetic peptides

Optimal polyvalent vaccine for cancer

Advantageous hydrogel composition

Method for preparing a stable TNF-α vaccine

Peptide composition as immunogen for the treatment of allergy

Peptide fragment of respiratory syncytial virus protein G, immunogenic agent, pharmaceutical composition containing it and preparation method

Antimultiorganism glycoconjugate vaccine

Reagents for detecting efavirenz

Methods and compositions for inducing autoimmunity in the treatment of cancers

Altering A B cell pathology using self-derived antigens in conjunction with specific-binding cytoreductive agent

Therapeutic vaccine peptide complex for preventing and treating disorders in mammals

Monoclonal antibodies specific for crack cocaine metabolites, a cell line producing the same, and crack cocaine conjugates

Product and composition containing a Concholepas concholepas hemocyanin (CCH) subunit, and a method of use thereof

Anti-tumor vasculature effects of human serum albumin derivatives

Multivalent meningococcal derivatized polysaccharide-protein conjugates and vaccine

Virus-like particle (VLP)-based vaccine against CVB4